MedPath

Radiation Therapy After Surgery in Treating Women With Phyllodes Tumor of the Breast

Not Applicable
Completed
Conditions
Breast Cancer
Interventions
Radiation: Adjuvant Radiotherapy
Registration Number
NCT00003404
Lead Sponsor
Dartmouth-Hitchcock Medical Center
Brief Summary

PURPOSE: This phase II trial studied how well radiation therapy works after surgery in treating women with phyllodes tumor of the breast.

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Radiation therapy following surgery may be effective in treating patients with phyllodes tumor of the breast.

Detailed Description

OBJECTIVES:

* Determine the local recurrence rate in women with phyllodes tumors of the breast previously treated with local excision with negative margins and are now treated with adjuvant radiotherapy.

* Determine the survival rate in patients treated with this regimen.

METHODS: Within 12 weeks after prior local excision or breast reexcision, patients underwent adjuvant radiotherapy 5 days a week for a total of 28 treatments. Patients were then followed every 6 months for 10 years.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
46
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Adjuvant RadiotherapyAdjuvant RadiotherapyAdjuvant radiation was started within 12 weeks of local excision or breast re-excision.
Primary Outcome Measures
NameTimeMethod
Local Recurrence Rate36 months after initial excision

Local recurrence rate of phyllodes tumors

Secondary Outcome Measures
NameTimeMethod
Survival RateApproximately 5 years

Survival will be tracked for 10 years after initial resection of first participant treated.

Trial Locations

Locations (1)

Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center

🇺🇸

Lebanon, New Hampshire, United States

© Copyright 2025. All Rights Reserved by MedPath